Direct and fast determination of paclitaxel, morphine and codeine in urine by micellar electrokinetic chromatography

Journal of Chromatography A

Volumn 1231, Issue , 2012, Pages 66-72

  Rodriguez J ^a   Castaneda G ^a   Contento, A M ^a   Munoz L ^a  

^a UNIVERSITY OF CASTILLA LA MANCHA   (Spain)

Author keywords

Cancer; Codeine; MEKC; Morphine; Paclitaxel; Urine analysis

Indexed keywords

CANCER; CODEINE; MEKC; MORPHINE; PACLITAXEL; URINE ANALYSIS;

DISEASES; LIQUID CHROMATOGRAPHY; PATIENT TREATMENT; SODIUM; SODIUM SULFATE;

BODY FLUIDS;

CODEINE; MORPHINE; PACLITAXEL;

ACCURACY; ARTICLE; CANCER THERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG URINE LEVEL; ELECTRIC POTENTIAL; HUMAN; HYDRODYNAMICS; LIMIT OF DETECTION; LIMIT OF QUANTITATION; MICELLAR ELECTROKINETIC CHROMATOGRAPHY; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; PROCESS OPTIMIZATION; SENSITIVITY AND SPECIFICITY; SEPARATION TECHNIQUE; TEMPERATURE; TIME; VALIDATION STUDY;

ANALGESICS, OPIOID; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CHROMATOGRAPHY, MICELLAR ELECTROKINETIC CAPILLARY; CODEINE; HUMANS; MORPHINE; NEOPLASMS; PACLITAXEL; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

EID: 84857791769     PISSN: 00219673     EISSN: 18733778     Source Type: Journal    
DOI: 10.1016/j.chroma.2012.02.003     Document Type: Article

References (50)

1. Portenoy R.K., Miransky J., Thaler H.T., et al. Cancer 1992, 70:1616.
2. Coyle N., Adelhardt J., Foley K.M., et al. J. Pain Symptom Manage. 1990, 5:83.
3. Hanks G.W., Justins D.M. Lancet 1992, 339:1031.
4. Grond S., Radbruch L., Meuser T. Pain 1999, 79:15.
5. Vielhaber A., Portenoy R.K. Hematol. Oncol. Clin. North Am. 2002, 16:527.
6. World Health Organization Cancer Pain Relief 1986, WHO Office of Publications, Geneva.
7. Cragg G.M., Schepartz S.A., Suffness M., Grever M.R. J. Nat. Prod. 1993, 56:1657.
8. Rowinsky E.K., Cazenave L.A., Donehower R.C. J. Natl. Cancer Inst. 1991, 83:1797.
9. Markman M. Yale J. Biol. Med. 1991, 64:583.
10. Holmes F.A., Waiters R.S., Theriault R.L., Forman A.D., Newton L.K., Raber M.N., Buzdar A.U., Frye D.K., Hortobagyi G.N. J. Natl. Cancer Inst. 1991, 83:1797.
11. Chang A., Kim K., Gliek J., Anderson T., Karp D., Johnson D. Proc. Am. Soc. Clin. Oncol. 1992, 11:981.
12. A.A. Forastiere, G. Adams, D. Neuberg, S. Taylor IV, Presented at the 2nd National Cancer Institute Workshop on Taxol and Taxus, September, 1992, session VIII, abstract 4.
13. Einzig A.I., Hochster H., Wiernik P.H., Trump D.L., Duteher J.P., Garowski E., Sasloff J., Smith T.J. Invest. New Drugs 1991, 9:59.
14. Schiff P.B., Horwitz S.B. Nature 1979, 22:665.
15. Lurcott G. Anesth. Prog. 1999, 45:154.
16. Hempel G., Lehmkuhl D., Krumpelmann S., Blaschke G., Boos J. J. Chromatogr. A 1996, 745:173.
17. Chan K.C., Alvarado A.B., Mcguirre M.T., Muschlik G.M., Issaq M.J., Snader K.M. J. Chromatogr. B 1994, 657:301.
18. Bitch F., Ma W., McDonald F., Nieder M., Shackleton C.J.L. J. Chromatogr. 1993, 615:273.
19. Poon G.K., Wade J., Bloomer J., Clarke S.E., Maltas J. Rapid Commun. Mass Spectrom. 1996, 10:1165.
20. Schellen A., Ooms B., van Gils M., Halmingh O., van der Vlis E., van de Lagemeat D., Verheij E. Rapid Commun. Mass Spectrom. 2000, 14:230.
21. Parise R.A., Ramanathan R.K., Zamboni W.C., Egorin M.J. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 2003, 783:231.
22. Stokvis E., Ouwehand M., Nan L.G., Kemper E.M., van Tellingen O., Rosing H., Beijnen J.M. J. Mass Spectrom. 2004, 39:1506.
23. Basileo G., Massimo Breda, Fonte G., Pisano R., James C.A. J. Pharm. Biomed. Anal. 2003, 32:591.
24. Alexander M.S., Kiser M.M., Culley T., Kern J.R., Dolan J.W., McChesney J.D., Zygmunt J., Bannister S.J. J. Chromatogr. B 2003, 785:253.
25. Parise R.A., Ramanathan R.K., Zamboni W.C., Egorin M.J. J. Chromatogr. B 2003, 783:231.
26. Mortier K.A., Lambert W.E. J. Chromatogr. A 2006, 1108:195.
27. Yu H., Straubinger R.M., Cao J., Wang H., Qu J. J. Chromatogr. A 2008, 1210:160.
28. Shuangming L., Yujie F., Yuangang Z., Rui S., YingWang, Zhang L., Hao L., Chengbo G., Efferth T. J. Pharm. Biomed. Anal. 2009, 49:81.
29. Zhang S.-Q., Song Y.-N., He X.-H., Zhong B.-H., Zhang Z.-Q. J. Pharm. Biomed. Anal. 2010, 51:1169.
30. Sparreboom A., van Telling O., Nooijen W.J., Beijnen J.H. Cancer Res. 1996, 56:2112.
31. Sparreboom A., van Telling O., Nooijen W.J., Beijnen J.H. Anticancer Drugs 1998, 9:1.
32. Badea I., Ciutaru D., Lazar L., Nicolescu D., Tudose A. J. Pharm. Biomed. Anal. 2004, 34:501.
33. Kim S.C., Yu J., Lee J.W., Park E.-S., Chi S.-C. J. Pharm. Biomed. Anal. 2005, 39:170.
34. Suno M., Ono T., Iida S., Umetsu N., Ohtaki K., Yamada T., Awaya T., Satomi M., Tasaki Y., Shimizu K., Matsubara K. J. Chromatogr. B 2007, 860:141.
35. Leu J.G., Chen B.X., Schiff P.B., Erlanger B.F. Cancer Res. 1993, 53:1388.
36. Grothaus P.G., Reybould T.J.G., Bignami G.S., Lazo G.B., Byrnes J.B. J. Immunol. Methods 1993, 158:5.
37. Chen B.G., Wang S.M., Liu R.H. J. Mass Spectrom. 2007, 42:1012.
38. Meatherall R. J. Anal. Toxicol. 2005, 29:301.
39. Lewis R.J., Johnson R.D., Hattrup R.A. J. Chromatogr. B 2005, 822:137.
40. Ropero-Miller J.D., Lambing M.K., Winecker R.E. J. Anal. Toxicol. 2002, 26:524.
41. Coles R., Kushnir M.M., Nelson G., McMillin G., Urry F.M. J. Anal. Toxicol. 2007, 31:1.
42. Gustavsson E., Andersson M., Stephanson N., Beck O. J. Mass Spectrom. 2007, 42:881.
43. Svensson J.O., Andersson M., Gustavsson E., Beck O. J. Anal. Toxicol. 2007, 31:81.
44. Musshoff F., Trafkowski J., Kuepper U., Madea B. J. Mass Spectrom. 2006, 41:633.
45. Edinboro L.E., Backer R.C., Poklis A. J. Anal. Toxicol. 2005, 29:704.
46. Al-Asmari A.I., Anderson R.A. J. Anal. Toxicol. 2007, 31:394.
47. Feng J., Wang L., Dai I., Harmon T., Bernert J.T. J. Anal. Toxicol. 2007, 31:359.
48. National Formulary 18, United States Pharmacopeia Convention, The United Stated Pharmacopeia (23rd ed.), Rockville, USA, 1995.
49. Plackett R.L., Burman J.P. Biometrika 1946, 33:305.
50. " Validation of compendial methods" USP 23, 1225; USPC, Rockville, Maryland, USA, 1994.